These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33685527)

  • 1. A pilot study of the impact of an exercise intervention on brain structure, cognition, and psychosocial symptoms in individuals with relapsing-remitting multiple sclerosis.
    Mayo CD; Harrison L; Attwell-Pope K; Stuart-Hill L; Gawryluk JR
    Pilot Feasibility Stud; 2021 Mar; 7(1):65. PubMed ID: 33685527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of white matter in cognitive impairment among relapsing remitting multiple sclerosis patients.
    Elkhooly M; Bao F; Raghib M; Millis S; Bernitsas E
    Mult Scler Relat Disord; 2023 Nov; 79():105030. PubMed ID: 37837669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional connectivity pre-post exercise intervention in individuals with relapsing-remitting multiple sclerosis.
    Saadat N; Mayo CD; Lacey C; Gawryluk JR
    Neuroreport; 2021 Sep; 32(13):1100-1105. PubMed ID: 34284447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple white matter tract abnormalities underlie cognitive impairment in RRMS.
    Yu HJ; Christodoulou C; Bhise V; Greenblatt D; Patel Y; Serafin D; Maletic-Savatic M; Krupp LB; Wagshul ME
    Neuroimage; 2012 Feb; 59(4):3713-22. PubMed ID: 22062194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis.
    Tao Y; XueSong Z; Xiao Y; YueZhi K; Xin W; YanPing T; Lei W; YongPing F
    Clin Neurol Neurosurg; 2021 Aug; 207():106805. PubMed ID: 34280674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of Gray Matter Atrophy and White Matter Damage to Cognitive Impairment in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients.
    Bernabéu-Sanz Á; Morales S; Naranjo V; Sempere ÁP
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33807060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.
    Alshehri A; Al-Iedani O; Arm J; Gholizadeh N; Billiet T; Lea R; Lechner-Scott J; Ramadan S
    Neuroradiol J; 2022 Oct; 35(5):592-599. PubMed ID: 35118885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging.
    Shi Z; Pan Y; Yan Z; Ding S; Hu H; Wei Y; Luo D; Xu Y; Zhu Q; Li Y
    Mult Scler Relat Disord; 2023 Mar; 71():104572. PubMed ID: 36821979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis.
    Vinciguerra C; Giorgio A; Zhang J; Nardone V; Brocci RT; Pastò L; Niccolai C; Stromillo ML; Mortilla M; Amato MP; De Stefano N
    Brain Imaging Behav; 2021 Aug; 15(4):2228-2233. PubMed ID: 33033983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
    Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
    Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and cognitive correlates of fatigue in progressive multiple sclerosis.
    Andreasen AK; Iversen P; Marstrand L; Siersma V; Siebner HR; Sellebjerg F
    Neurol Res; 2019 Feb; 41(2):168-176. PubMed ID: 30513278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor imaging findings in the multiple sclerosis patients and their relationships to various aspects of disability.
    Pokryszko-Dragan A; Banaszek A; Nowakowska-Kotas M; Jeżowska-Jurczyk K; Dziadkowiak E; Gruszka E; Zagrajek M; Bilińska M; Budrewicz S; Sąsiadek M; Bladowska J
    J Neurol Sci; 2018 Aug; 391():127-133. PubMed ID: 30103962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
    Conway DS; Planchon SM; Oh SH; Nakamura K; Thompson NR; Sakaie K; Ontaneda D
    Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical diffusion kurtosis imaging and thalamic volume are associated with cognitive and walking performance in relapsing-remitting multiple sclerosis.
    Nygaard MKE; Langeskov-Christensen M; Dalgas U; Eskildsen SF
    J Neurol; 2021 Oct; 268(10):3861-3870. PubMed ID: 33829319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis.
    Saposnik G; Andhavarapu S; Sainz de la Maza S; Castillo-Triviño T; Borges M; Barón BP; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco MR; García-Soto JD; Del Campo-Amigo M; Navarro-Cantó L; Agüera E; Garcés M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; García-Arcelay E; Terzaghi M; Gómez-Ballesteros R; Maurino J
    Mult Scler Relat Disord; 2022 Dec; 68():104138. PubMed ID: 36029707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modern Technology in Multi-Shell Diffusion MRI Reveals Diffuse White Matter Changes in Young Adults With Relapsing-Remitting Multiple Sclerosis.
    Beaudoin AM; Rheault F; Theaud G; Laberge F; Whittingstall K; Lamontagne A; Descoteaux M
    Front Neurosci; 2021; 15():665017. PubMed ID: 34447292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.